4-Ethyl-2,3-Dioxo-1-Piperazine Carbonyl Chloride Bulk Price 2026 Market Analysis
- Process Chemistry: Optimized synthesis route ensures consistent reaction yields and minimal impurity profiles.
- Supply Chain Logic: Factory-direct bulk price stability mitigates volatility in tonnage quantities.
- Commercial Viability: Full regulatory compliance and scalable manufacturing process for antibiotic intermediates.
The pharmaceutical intermediate market is shifting towards greater transparency and supply chain resilience as we approach 2026. For process chemists and procurement officers targeting 4-Ethyl-2,3-dioxo-1-piperazine carbonyl chloride (CAS: 59703-00-3), understanding the correlation between synthesis complexity and commercial pricing is critical. As a premier global manufacturer, NINGBO INNO PHARMCHEM CO.,LTD. stands at the forefront of delivering this key cephalosporin intermediate with uncompromising industrial purity.
This compound, essential for the synthesis of Cefbuperazone and various histone deacetylase inhibitors, requires strict moisture control and specialized handling. Market data indicates significant price disparities between catalog reagents and contract manufacturing outputs. This analysis dissect the technical and commercial factors driving the bulk price landscape for the coming fiscal year.
Technical Specifications and Quality Parameters
For R&D teams validating raw materials, the physicochemical properties dictate the storage and handling protocols. The material is moisture-sensitive and typically appears as a white to off-white powder. Maintaining industrial purity above 98% is essential to prevent downstream side reactions during antibiotic synthesis. Below are the critical quality attributes expected from a tier-one supplier.
| Parameter | Specification | Test Method |
|---|---|---|
| CAS Number | 59703-00-3 | Registry |
| Molecular Formula | C7H9ClN2O3 | Calculated |
| Molecular Weight | 204.61 g/mol | MS |
| Purity (HPLC) | ≥ 98.0% | Area Normalization |
| Appearance | White to Off-White Powder | Visual |
| Storage Conditions | 2-8°C, Under Inert Gas | Stability Study |
| Solubility | Soluble in Chloroform | Experimental |
Tiered Pricing Structures for Kilogram and Ton Quantities
Market intelligence reveals that unit costs decrease exponentially as order volume shifts from gram-scale laboratory packs to multi-kilogram production batches. Small-scale catalog listings often reflect packaging and handling overheads rather than the intrinsic value of the chemical. For industrial applications, the manufacturing process efficiency allows for significant cost reductions at scale.
Procurement teams should anticipate tiered pricing models where kilogram quantities offer a distinct advantage over gram-level purchasing. Establishing a long-term supply agreement ensures batch-to-batch consistency and locks in favorable rates against market fluctuations. This strategy is vital for maintaining margin stability in the production of second-generation cephalosporins.
Comparing Catalog Rates Versus Contract Manufacturing Costs
While catalog rates provide a baseline for spot purchases, they rarely reflect the true cost of goods for commercial synthesis. Catalog pricing often includes premiums for immediate availability and small-pack logistics. In contrast, contract manufacturing leverages optimized synthesis route planning and bulk raw material sourcing to drive down the cost per unit.
When evaluating suppliers, it is crucial to look beyond the headline price. Factors such as impurity profiles, residual solvent limits, and the availability of a comprehensive COA (Certificate of Analysis) add significant value. A lower catalog price may incur hidden costs during process validation if the material fails to meet strict pharmacopeial standards.
Requesting Custom Quotes for Large Scale Procurement
For facilities planning tonnage production, standard pricing lists are insufficient. Custom quotes allow for the negotiation of specific packaging, delivery schedules, and quality thresholds. When sourcing high-purity 3-dioxo-piperazine carbonyl chloride, buyers should engage directly with the production team to align technical specifications with commercial requirements.
Direct engagement facilitates a clearer understanding of lead times and capacity allocation. This is particularly important for moisture-sensitive intermediates where production slots may be limited by specialized drying and packaging capabilities. Securing a dedicated production line ensures that your supply chain remains robust against global logistical disruptions.
Regulatory Compliance and Scalability
Executive decision-makers must prioritize regulatory adherence alongside cost efficiency. Scalable production requires a manufacturer capable of maintaining compliance with international standards such as REACH and TSCA. NINGBO INNO PHARMCHEM CO.,LTD. invests heavily in quality assurance systems to ensure that every batch meets the rigorous demands of the global pharmaceutical market.
By partnering with a verified manufacturer, companies mitigate the risk of supply chain interruptions due to regulatory non-compliance. This security is invaluable for long-term product lifecycle management and ensures continuous availability of critical antibiotic intermediates.
To secure your supply chain for the upcoming fiscal year, we invite you to contact our technical sales team for a batch-specific COA, SDS, or bulk pricing quote. Let us demonstrate how our optimized manufacturing capabilities can support your production goals.